Literature DB >> 6975943

Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function.

S L Swain.   

Abstract

The effect of anti-Lyt2 on the generation of helper T-cell function and on cytotoxic effects specific for subregions of the major histocompatibility complex (MHC) was determined. The addition of anti-Lyt2 without complement to in vitro cultures blocked the generation of allogeneic MHC-induced help and lymphokine production and cytotoxic effects when the response was directed against allogeneic class 1 MHC antigens (K and D gene products of the mouse H-2 complex) but had no effect when these responses were specific for class 2 MHC antigens (I region gene products). Anti-Lyt2 failed to block the response of help induced to allogeneic mixed lymphocyte-stimulating determinants or the production of lymphokines by T cells specific for class 1 MHC antigens when concanavalin A lectin was used to induce activity. These and earlier results indicate that the ability of anti-Lyt2 antisera to block function is correlated with T cell specificity for class 1 MHC antigens not with the functional activity of the cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975943      PMCID: PMC349203          DOI: 10.1073/pnas.78.11.7101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Helper T cells recognise antigen and macrophage surface components simultaneously.

Authors:  J W Kappler; P C Marrack
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

Review 2.  Cytotoxic T lymphocyte membrane components: an analysis of structures related to function.

Authors:  A K Kimura; H Wigzell
Journal:  Contemp Top Mol Immunol       Date:  1977

3.  Alloantigen-induced T helper activity. I. Minimal genetic differences necessary to induce a positive allogeneic effect.

Authors:  P R Panfili; R W Dutton
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Helper cells activated by allogeneic H-2K or H-2D differences have a Ly phenotype distinct from those responsive to I differences.

Authors:  S L Swain; P R Panfili
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

5.  Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera.

Authors:  E Nakayama; H Shiku; E Stockert; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Alternative pathways of T lymphocyte activation.

Authors:  F H Bach; B J Alter
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

7.  Histocompatibility antigens controlled by the I region of the murine H-2 complex. II. K/D region compatibility is not required for I-region cell-mediated lymphocytotoxicity.

Authors:  J Klein; C L Chiang; V Hauptfeld
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

8.  T-lymphocyte response to H-2 mutants. I. Proliferation is dependent on Ly 1+2+ cells.

Authors:  P J Wettstein; D W Bailey; L E Mobraaten; J Klein; J A Frelinger
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

9.  Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus.

Authors:  N Shinohara; D H Sachs
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.

Authors:  J Watson; S Gillis; J Marbrook; D Mochizuki; K A Smith
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  68 in total

Review 1.  Treatment of an autoimmune disease with "classical" T cell veto: a proposal.

Authors:  U D Staerz; Y Qi
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  Analysis of the function of L3T4+ T cells by in vivo treatment with monoclonal antibody to L3T4.

Authors:  D Wofsy; W E Seaman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  Crystallization and preliminary X-ray structural studies of a high-affinity CD8alphaalpha co-receptor to pMHC.

Authors:  David K Cole; Pierre J Rizkallah; Malkit Sami; Nikolai M Lissin; Feng Gao; John I Bell; Jonathan M Boulter; Meir Glick; Anne Lise Vuidepot; Bent K Jakobsen; George F Gao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-02-12

4.  Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency.

Authors:  M E North; G P Spickett; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

5.  Expression of L3T4 molecules on Lyt-2+, class II-restricted antigen-specific T suppressor lymphocytes.

Authors:  J Heuer; J Degwert; E Kölsch
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 6.  Antigen-major histocompatibility complex-T cell receptors: inquiries into the immunological ménage à trois.

Authors:  J Klein
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

7.  The amino-terminal sequences of Ly-2 and Ly-3.

Authors:  I D Walker; B J Murray; L Kirszbaum; G W Chambers; N J Deacon; I F McKenzie
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

8.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.

Authors:  M J Reddehase; F Weiland; K Münch; S Jonjic; A Lüske; U H Koszinowski
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

9.  Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5.

Authors:  B E Bierer; Y Nishimura; S J Burakoff; B R Smith
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 10.  Functional sites of human class I MHC molecules: paradigms a dozen?

Authors:  P Parham
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.